Mastek announced its financial results for the second quarter of FY27, ending September 30, 2026. The company reported a revenue of ₹1,018.7 crore, marking a 3.4% increase quarter-over-quarter. Key highlights include 53 new AI deals signed, contributing significantly to the order book, and a strategic partnership with Innovaccer to drive AI transformation in healthcare. The company also noted strong momentum in the UK & Europe and North America markets.
Mastek Reports Strong Q2FY27 Performance
Mastek has announced its financial results for the second quarter and half-year ended September 30, 2026. The company’s revenue from operations for Q2FY27 stood at ₹1,018.7 crore, showing a 3.4% increase sequentially and an 8.3% year-on-year growth. The overall income for the quarter was ₹1,030.4 crore, up by 3.3% QoQ.
Key Business Highlights
In Q2FY27, Mastek signed 53 new AI deals, which now constitute approximately 45% of the overall order book. A significant development was the signing of a partnership with Innovaccer, a leader in data and AI platforms for healthcare and life sciences, aimed at accelerating AI transformation growth. The North America region continued to exhibit high growth in its order book.
Geographical and Sectoral Performance
Commenting on the results, Umang Nahata, CEO, highlighted Mastek’s positioning as an AI transformational company, with AI-led solutions gaining traction. The UK & Europe business demonstrated robust sequential revenue growth of 4.1%, driven by momentum in financial services and the public sector. North America also saw sequential growth and a strong order book, while the Middle East faced geopolitical uncertainties.
Deepak Kedia, CFO, noted a strong quarter with 2.4% constant currency revenue growth despite macro challenges. The Operating EBITDA margin was 14.4%, impacted by annual increments. The company emphasized consistent improvement in its cash position, providing a strong foundation for strategic investments.
Financial Summary
The consolidated financial highlights for Q2FY27 indicate an Operating EBITDA of ₹146.2 crore, with an Operating EBITDA margin of 14.4%. Net Profit stood at ₹105.7 crore, resulting in a PAT margin of 10.3%. The diluted EPS was ₹33.9. The 12-month order backlog was reported at ₹2,742.8 crore, reflecting a 10.4% growth year-on-year in rupee terms.
Key Wins and Achievements
During the quarter, Mastek secured several key wins, including a Service-as-Software engagement with a US senior care provider and a five-year strategic partnership with a global dental technology leader. The company also highlighted its achievements in cybersecurity and process transformation projects with UK government entities.
Source: BSE
